THERMO FISHER SCIENTIFIC INC. TMO 84.45
Health Care · NYSE · Data as of 2026-10-30
THERMO FISHER SCIENTIFIC INC. (TMO) has delivered +11.4% annualized revenue growth, +15.5% earnings growth, and +12.9% dividend growth over 10 years of data. Ranked #50 of 1968 stocks overall and #7 of 260 in the Health Care sector by Steady Score.
About THERMO FISHER SCIENTIFIC INC.
Company Overview
Thermo Fisher Scientific supplies instruments, laboratory equipment, reagents, consumables, diagnostics and services that support scientific research and healthcare. Its customers include pharmaceutical and biotechnology companies, hospitals, clinical laboratories, universities, government agencies and industrial organizations. The portfolio covers activities from biological discovery and analytical testing to clinical trials, drug manufacturing and routine laboratory operations. The company serves these markets through a global commercial and service network.
Read more
Business Model & Revenue
Revenue comes from instrument sales, recurring consumables and reagents, laboratory distribution, software, maintenance and outsourced pharmaceutical services. The company sells directly, through e-commerce and through distributors under brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Patheon and PPD. Its broad channel and installed instrument base create repeat demand, while clinical research and manufacturing services are delivered under customer contracts.
Key Facts & Market Position
Thermo Fisher reports four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. This breadth gives it exposure to research funding, healthcare testing and biopharma development. Competitive strengths include technical depth, global distribution and the ability to bundle products, procurement and services across a customer's workflow.